AI Assistant
Blog
Pricing
Log In
Sign Up
The risk of recurrence within the first five years is very low in patients with papillary thyroid carcinoma treated with radioiodine
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
